Private area
Contact Us
Total Visits
| Views | |
|---|---|
| Efficacy ... | 397 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Efficacy ... | 6 | 14 | 10 | 10 | 19 | 157 | 6 |
File Visits
| Views | |
|---|---|
| efficacy_177lu_dotatate_metastatic_neuroendocrine_neoplasms_different_locations_data_septralu_study_2023.pdf | 219 |
| efficacy_177lu_dotatate_metastatic_neuroendocrine_neoplasms_different_locations_data_septralu_study_2023_material_suplementari2.pdf | 43 |
| efficacy_177lu_dotatate_metastatic_neuroendocrine_neoplasms_different_locations_data_septralu_study_2023_material_suplementari4.pdf | 37 |
| efficacy_177lu_dotatate_metastatic_neuroendocrine_neoplasms_different_locations_data_septralu_study_2023_material_suplementari5.pdf | 35 |
| efficacy_177lu_dotatate_metastatic_neuroendocrine_neoplasms_different_locations_data_septralu_study_2023_material_suplementari7.pdf | 33 |
| efficacy_177lu_dotatate_metastatic_neuroendocrine_neoplasms_different_locations_data_septralu_study_2023_material_suplementari6.pdf | 33 |
| efficacy_177lu_dotatate_metastatic_neuroendocrine_neoplasms_different_locations_data_septralu_study_2023_material_suplementari3.pdf | 31 |
| efficacy_177lu_dotatate_metastatic_neuroendocrine_neoplasms_different_locations_data_septralu_study_2023_material_suplementari8.pdf | 30 |
| efficacy_177lu_dotatate_metastatic_neuroendocrine_neoplasms_different_locations_data_septralu_study_2023_material_suplementari1.pdf | 28 |
Top country views
| Views | |
|---|---|
| United States | 196 |
| Spain | 69 |
| Singapore | 25 |
| Russia | 16 |
| Germany | 14 |
| France | 11 |
| Hong Kong | 11 |
| China | 10 |
| Finland | 6 |
| India | 6 |
Top cities views
| Views | |
|---|---|
| Orangeburg | 144 |
| Singapore | 19 |
| Hong Kong | 11 |
| Madrid | 11 |
| Beijing | 9 |
| Nuremberg | 9 |
| Ashburn | 8 |
| Barcelona | 7 |
| Paris | 7 |
| Almont | 6 |
